MD Anderson Cancer Center is developing a new campus in Sugar Land on roughly 31 acres that will total about 500,000 square feet and is expected to open in 2028, the center’s infrastructure official told the Tax Increment Reinvestment Zone No. 4 board on Dec. 15.

Kent Postma, vice president of clinical infrastructure development and growth at MD Anderson, said the project broke ground in March 2025 and will house about 530 employees, most of whom live in the Sugar Land market. "We're happy that we we're gonna call Sugar Land home, for approximately 530 employees," he said.

Postma described multidisciplinary clinics covering specialties including gastroenterology, breast, gynecology and thoracic care; infusion therapy and cellular therapy; diagnostic imaging; pathology and lab medicine; and radiation therapy. He said the campus is designed to support short overnight stays of less than 72 hours and will open with four operating rooms, expanding to eight over time. "They are all 100% MD Anderson employees. No contracted doctors or employees," Postma said.

On facility phasing, Postma said the shell and core for the entire building will be ready on day one and roughly 72% of space will be operational at opening; services such as radiation that require specialized vaults may occupy fewer rooms initially while the infrastructure is in place. He told the board the project had gained time on the schedule and was running about 30 days ahead.

The board's exchange with MD Anderson emphasized local job opportunities and consolidation of leased regional sites: Postma said clinicians at MD Anderson's Lake Point leased facility will move to the new campus and the leased site will close.

The board received the presentation as part of a broader development update; no formal board action was required on the MD Anderson project during the meeting. The next steps described by MD Anderson were continued construction toward the 2028 target and internal staffing and equipment planning.